<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="section" /><meta name="keywords" content="Local anaesthetics see Anaesthesia, local; Anaesthesia: local; Vasoconstrictors: local anaesthesia; Adrenaline: local anaesthesia; Lidocaine: local anaesthesia: dental; Anaesthesia: local: dental; Vasoconstrictors: local anaesthesia: dental; Dental prescribing: anaesthesia: local; Dental prescribing: anaesthesia: vasoconstrictors; Adrenaline: local anaesthesia; Articaine; Carticaine see Articaine; Mepivacaine; Prilocaine: felypressin with; Felypressin" /><meta name="IX" content="Anaesthesia: local; Vasoconstrictors: local anaesthesia; Adrenaline: local anaesthesia; Lidocaine: local anaesthesia: dental; Anaesthesia: local: dental; Vasoconstrictors: local anaesthesia: dental; Dental prescribing: anaesthesia: local; Dental prescribing: anaesthesia: vasoconstrictors; Adrenaline: local anaesthesia; Articaine; Mepivacaine; Prilocaine: felypressin with; Felypressin" /><meta name="IXN" content="Local anaesthetics see Anaesthesia, local; Carticaine see Articaine" /><title>15.2 Local anaesthesia: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="6684.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="6684.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=6684.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2082.htm">15 Anaesthesia</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="6682.htm" title="Previous: DANTROLENE SODIUM">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="213800.htm" title="Next: Articaine">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_6684">15.2 Local anaesthesia</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i715.htm" title="Go to appendix 1">Adrenaline (epinephrine)</a>).</div><div><div id="_214131"><div class="cN"><h3 class="cBP">Important</h3><p>The drugs in section 15.2 should only be administered
by, or under the direct supervision of, personnel experienced in their
use, with adequate training in anaesthesia and airway management,
and should not be administered parenterally unless adequate resuscitation
equipment is available.</p></div></div><p>The use of <span>local anaesthetics</span> by injection or by application to mucous membranes to produce local
analgesia is discussed in this section.</p><p>See also <a title=" Local preparations for anal and rectal disorders" href="2261.htm#_2261">section 1.7</a> (anus), <a title=" Local anaesthetics" href="5524.htm#_5524">section 11.7</a> (eye), <a title=" Drugs acting on the oropharynx" href="5679.htm#_5679">section 12.3</a> (oropharynx), and <a title=" Topical local anaesthetics and antipruritics" href="5820.htm#_5820">section 13.3</a> (skin).</p><div class="cAZ"><h2>Use of local anaesthetics</h2> <p class="cAX">Local anaesthetic drugs
act by causing a reversible block to conduction along nerve fibres.
They vary widely in their potency, toxicity, duration of action, stability,
solubility in water, and ability to penetrate mucous membranes. These
factors determine their application, e.g. topical (surface), infiltration,
peripheral nerve block, intravenous regional anaesthesia (Bier’s block),
plexus, epidural (extradural), or spinal (intrathecal or subarachnoid)
block. Local anaesthetics may also be used for postoperative pain
relief, thereby reducing the need for analgesics such as opioids.</p></div><div id="_120025"><div class="cAZ"><h2>Administration</h2> <p class="cAX">The dose of local anaesthetic depends
on the injection site and the procedure used. In determining the safe
dosage, it is important to take account of the rate of absorption
and excretion, and of the potency. The patient’s age, weight, physique,
and clinical condition, and the vascularity of the administration
site and the duration of administration, must also be considered.</p><p>Uptake of local anaesthetics into the systemic circulation determines
their duration of action and produces toxicity.</p><p><span id="_6684.6">Great care must be taken to avoid accidental intravascular injection;
local anaesthetic injections should be given slowly in
order to detect inadvertent intravascular administration. When prolonged analgesia is required, a long-acting local anaesthetic
is preferred to minimise the likelihood of cumulative systemic toxicity. Local anaesthesia around the oral cavity may impair swallowing and therefore increases the risk of aspiration.</span></p><p><span id="_6684.5">Following most regional anaesthetic procedures, maximum arterial
plasma concentration of anaesthetic develops within about 10 to 25
minutes, so <b>careful surveillance</b> for toxic effects
(see <a title="BNF:target-block: Local anaesthetics toxicity and side-effects" href="6684.htm#_209262">Toxicity and Side-effects</a>)
is necessary during the first 30 minutes after injection</span>. </p><p>Epidural anaesthesia is commonly used during surgery, often
combined with general anaesthesia, because of its protective effect
against the stress response of surgery. It is often used when good
postoperative pain relief is essential (e.g. major thoracic or intra-abdominal
surgery).</p></div></div><div id="_209248"><div class="cAZ"><h2>Use of vasoconstrictors</h2> <p class="cAX"><span>Local anaesthetics</span> cause dilatation of blood vessels. The addition of a vasoconstrictor
such as <b>adrenaline</b> (<b>epinephrine</b>) to the
local anaesthetic preparation diminishes local blood flow, slowing
the rate of absorption and thereby prolonging the anaesthetic effect.
Great care should be taken to avoid inadvertent intravenous administration
of a preparation containing adrenaline, and it <span id="_214134"></span>is <span id="_212098"><b>not</b> advisable to give adrenaline with
a local anaesthetic injection in digits or appendages</span> because of the risk of ischaemic necrosis.</p><p>Adrenaline must be used in a low concentration when administered
with a local anaesthetic (but see also <a title="BNF:target-block: Local anaesth for dental" href="6684.htm#_6684.2">Dental Anaesthesia</a>). The total dose
of adrenaline should <b>not</b> exceed 500 micrograms and it is essential not to exceed a concentration of
1 in 200 000 (5 micrograms/mL) if more than 50 mL of the mixture is
to be injected. Care must also be taken to calculate
a safe maximum dose of local anaesthetic when using combination products.
For prescribing information on adrenaline, see <a title=" Cardiopulmonary resuscitation" href="27050.htm#_27050">section 2.7.3</a>. For drug interactions of adrenaline,
see Appendix 1 (sympathomimetics).</p><p>In patients with severe hypertension or unstable cardiac rhythm,
the use of adrenaline with a local anaesthetic may be hazardous. For
these patients an anaesthetic without adrenaline should be used.<span id="_214349"></span></p></div></div><div id="_6684.2"><div class="cAZ"><h2>Dental anaesthesia</h2> <p class="cAX"><b><span>Lidocaine</span></b> is widely used in dental procedures;
it is most often used in combination with <b><span>adrenaline</span></b> (epinephrine). <span>Lidocaine</span> 2% combined
with <span>adrenaline</span> 1 in 80 000  (12.5 micrograms/mL)
is a safe and effective preparation; there is no justification for
using higher concentrations of adrenaline. See also <a title="BNF:target-block: Use of vasoconstrictors" href="6684.htm#_209248">Use of Vasoconstrictors</a>.</p><p>The local anaesthetics <b><span>articaine</span></b> and <b><span>mepivacaine</span></b> are also used in dentistry; they are available in cartridges suitable
for dental use. <span>Mepivacaine</span> is available with or
without <span>adrenaline</span> and <span>articaine</span> is available with <span>adrenaline</span>.</p><p>In patients with severe hypertension or unstable
cardiac rhythm, mepivacaine without adrenaline may be used. Alternatively, <b><span>prilocaine</span></b> with or without <span>felypressin</span> can be used but there
is no evidence that it is any safer. Felypressin can cause coronary
vasoconstriction when used at high doses; limit dose in patients with
coronary artery disease.</p></div></div><div id="_209256"><div class="cAZ"><h2>Cautions of local anaesthetics</h2> <p class="cAX">Local anaesthetics
should be administered with caution in children, elderly or debilitated
patients (consider dose reduction), or in patients with impaired cardiac conduction, cardiovascular
disease, hypovolaemia, shock, impaired respiratory function, epilepsy, or myasthenia
gravis. See also <a title="BNF:target-block: lignocaine administration" href="6684.htm#_120025">Administration</a> and <a title="BNF:target-block: Use of vasoconstrictors" href="6684.htm#_209248">Use of Vasoconstrictors</a>, above.</p></div></div><div id="_209257"><div class="cAZ"><h2>Contra-indications of local anaesthetics</h2> <p class="cAX">Local
anaesthetics should not be injected into inflamed or infected tissues
nor should they be applied to damaged skin. In such circumstances, increased absorption into the blood increases
the possibility of systemic side-effects, and the local anaesthetic
effect may also be reduced by altered local pH. See also <a title="BNF:target-block: Use of vasoconstrictors" href="6684.htm#_209248">Use of Vasoconstrictors</a>.</p><p><span id="_214350">Local anaesthetic preparations containing preservatives should not
be used for caudal, epidural, or spinal block, or for intravenous
regional anaesthesia (Bier’s block)</span>.</p><p>Local anaesthetics can cause ototoxicity and should
not be applied to the middle ear. They are also contra-indicated
in patients with complete heart block.</p></div></div><div id="_209262"><div class="cAZ"><h2>Toxicity and side-effects</h2> <p class="cAX">A single application
of a topical lidocaine preparation does not generally cause systemic
side-effects. Toxic effects after administration of local anaesthetics
are a result of excessively high plasma concentrations; severe toxicity
usually results from inadvertent intravascular injection or too rapid
injection.</p><p>The systemic toxicity of local anaesthetics mainly involves
the central nervous and cardiovascular systems. CNS effects include
a feeling of inebriation and lightheadedness followed by drowsiness,
numbness of the tongue and perioral region, restlessness, paraesthesia
(including sensations of hot and cold), dizziness, blurred vision,
nausea and vomiting, muscle twitching, tremors, and convulsions. Transient
excitation may also occur, followed by depression with drowsiness,
respiratory failure, unconsciousness, and coma. Effects on the cardiovascular
system include myocardial depression and peripheral vasodilatation
resulting in hypotension and bradycardia; arrhythmias and cardiac
arrest can occur.</p><p>Hypersensitivity reactions occur mainly with the ester-type
local anaesthetics, such as tetracaine; reactions are less frequent
with the amide types, such as articaine, bupivacaine, levobupivacaine,
lidocaine, mepivacaine, prilocaine, and ropivacaine. Cross-sensitivity
reactions may be avoided by using the alternative chemical type.</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_213800"><a href="213800.htm" title="Articaine">Articaine</a></li><li id="_6696"><a href="6696.htm" title="Bupivacaine">Bupivacaine</a></li><li id="_86454"><a href="86454.htm" title="Levobupivacaine">Levobupivacaine</a></li><li id="_6685"><a href="6685.htm" title="Lidocaine">Lidocaine</a></li><li id="_209328"><a href="209328.htm" title="Mepivacaine">Mepivacaine</a></li><li id="_6701"><a href="6701.htm" title="Prilocaine">Prilocaine</a></li><li id="_57997"><a href="57997.htm" title="Ropivacaine">Ropivacaine</a></li><li id="_40702"><a href="40702.htm" title="Tetracaine">Tetracaine</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="6682.htm">Previous: DANTROLENE SODIUM</a> | <a class="top" href="6684.htm#">Top</a> | <a accesskey="]" href="213800.htm">Next: Articaine</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>